FDA authorizes first at home, over the counter COVID-19 test

The FDA announced it has issued an emergency use authorization for the Cue COVID-19 test, the first at home, over the counter test for COVID-19.The agency authorized the test for non-prescription, home use in adults for self-swabbing and for children aged 2 years and older when swabbed by an adult.“The authorization of this new diagnostic…

HBV antiviral treatment linked with reduced cirrhosis risk

Patients with chronic hepatitis B who received antiviral therapy experienced a significant reduction in risk for cirrhosis, according to study results.“Few studies have specifically focused on the benefits of HBV antiviral therapies in non-Asian and noncirrhotic cohorts, especially as it relates to evaluating the impact of treatment on the risk of developing cirrhosis and death,”…

H. pylori infection high among Hispanic/Latino individuals

Researchers observed high helicobacter pylori infection seroprevalence among Hispanic/Latino individuals, which varied by nativity and background, according to study results.“Our findings demonstrated a high burden of H. pylori infection in all Hispanics/Latinos and identify specific vulnerable groups by self-reported background and sociodemographic/clinical characteristics,” Sabrina H. Tsang, PhD, MPH, from the division of cancer epidemiology and…